Small Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Small Pharma has a total shareholder equity of CA$8.0M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$12.9M and CA$4.9M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
| Interest coverage ratio | n/a |
| Cash | CA$7.68m |
| Equity | CA$8.05m |
| Total liabilities | CA$4.88m |
| Total assets | CA$12.92m |
Financial Position Analysis
Short Term Liabilities: DMT's short term assets (CA$12.4M) exceed its short term liabilities (CA$4.7M).
Long Term Liabilities: DMT's short term assets (CA$12.4M) exceed its long term liabilities (CA$154.3K).
Debt to Equity History and Analysis
Debt Level: DMT is debt free.
Reducing Debt: DMT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DMT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: DMT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 47.3% each year